Curetis delivers clear direction for rapid diagnosis of pneumonia in hospitalized patients with the FDA-cleared Unyvero LRT panel that quickly detects 29 most clinically relevant bacteria and resistance genes to inform rapid diagnosis and earlier antibiotic treatment decisions for these critically ill patients. To help optimize antibiotic therapy, Unyvero points the way.